FDA
-
-
-
-
-
-
-
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / NCNP-01) Phase 3 Clinical Trial (RACER53 Study)
326,366 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

